Healthcare utilization and costs associated with acute lymphoblastic leukemia in children with and without Down syndrome.

Uma H AthaleRinku SutradharVicky R BreakeyQing LiMylene BassalPaul GibsonSerina PatelLaura Wheaton Jason D PoleNicole MittmanPetros PechlivanoglouSumit Gupta

Published in: Pediatric blood & cancer (2022)

Healthcare utilization and treatment costs of DS-ALL patients are substantially higher than those of non-DS-ALL. Our data provide a baseline for future DS-specific cost-effectiveness studies.

Keyphrases

healthcare
acute lymphoblastic leukemia
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
young adults
prognostic factors
peritoneal dialysis
electronic health record
current status
big data
health information
social media
artificial intelligence
data analysis